These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 36851328)

  • 1. Skin-Based Vaccination: A Systematic Mapping Review of the Types of Vaccines and Methods Used and Immunity and Protection Elicited in Pigs.
    Có-Rives I; Chen AY; Moore AC
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs.
    van Rooij EM; Haagmans BL; de Visser YE; de Bruin MG; Boersma W; Bianchi AT
    Vet Immunol Immunopathol; 1998 Nov; 66(2):113-26. PubMed ID: 9860185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing Immunogenicity of Influenza Vaccine in the Elderly through Intradermal Vaccination: A Literature Analysis.
    Quach HQ; Kennedy RB
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.
    Bernstein DI; Guptill J; Naficy A; Nachbagauer R; Berlanda-Scorza F; Feser J; Wilson PC; Solórzano A; Van der Wielen M; Walter EB; Albrecht RA; Buschle KN; Chen YQ; Claeys C; Dickey M; Dugan HL; Ermler ME; Freeman D; Gao M; Gast C; Guthmiller JJ; Hai R; Henry C; Lan LY; McNeal M; Palm AE; Shaw DG; Stamper CT; Sun W; Sutton V; Tepora ME; Wahid R; Wenzel H; Wohlbold TJ; Innis BL; García-Sastre A; Palese P; Krammer F
    Lancet Infect Dis; 2020 Jan; 20(1):80-91. PubMed ID: 31630990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs.
    Borggren M; Nielsen J; Karlsson I; Dalgaard TS; Trebbien R; Williams JA; Fomsgaard A
    Vaccine; 2016 Jul; 34(32):3634-40. PubMed ID: 27211039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses induced by inactivated porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in neonatal pigs using different adjuvants.
    Vreman S; Stockhofe-Zurwieden N; Popma-de Graaf DJ; Savelkoul HFJ; Barnier-Quer C; Collin N; Collins D; McDaid D; Moore AC; Rebel JMJ
    Vet Immunol Immunopathol; 2021 Feb; 232():110170. PubMed ID: 33383553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneedle-based vaccines.
    Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
    Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the immune response induced by intradermal vaccination by using a needle-less system in comparison with the intramuscular route in conventional pigs.
    Ferrari L; Borghetti P; Gozio S; De Angelis E; Ballotta L; Smeets J; Blanchaert A; Martelli P
    Res Vet Sci; 2011 Feb; 90(1):64-71. PubMed ID: 20546827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.
    Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
    Sci Rep; 2021 Nov; 11(1):23107. PubMed ID: 34845289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal vaccination with un-adjuvanted sub-unit vaccines triggers skin innate immunity and confers protective respiratory immunity in domestic swine.
    Le Luduec JB; Debeer S; Piras F; Andréoni C; Boudet F; Laurent P; Kaiserlian D; Dubois B
    Vaccine; 2016 Feb; 34(7):914-22. PubMed ID: 26768129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis.
    Jaiswal N; Singh S; Agarwal A; Chauhan A; Thumburu KK; Kaur H; Singh M
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011780. PubMed ID: 31858595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routing dependent immune responses after experimental R848-adjuvated vaccination.
    van Aalst S; Jansen MAA; Ludwig IS; van der Zee R; van Eden W; Broere F
    Vaccine; 2018 Mar; 36(11):1405-1413. PubMed ID: 29409680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study.
    Van Damme P; Arnou R; Kafeja F; Fiquet A; Richard P; Thomas S; Meghlaoui G; Samson SI; Ledesma E
    BMC Infect Dis; 2010 May; 10():134. PubMed ID: 20504306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
    Denis F; Alain S; Ploy MC
    Med Sci (Paris); 2007 Apr; 23(4):379-85. PubMed ID: 17433227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced immunogenicity and protective efficacy of a tetravalent dengue DNA vaccine using electroporation and intradermal delivery.
    Williams M; Ewing D; Blevins M; Sun P; Sundaram AK; Raviprakash KS; Porter KR; Sanders JW
    Vaccine; 2019 Jul; 37(32):4444-4453. PubMed ID: 31279565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines.
    Martelli P; Saleri R; Cavalli V; De Angelis E; Ferrari L; Benetti M; Ferrarini G; Merialdi G; Borghetti P
    Vet Microbiol; 2014 Jan; 168(2-4):357-64. PubMed ID: 24332702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial.
    Li JX; Hou LH; Meng FY; Wu SP; Hu YM; Liang Q; Chu K; Zhang Z; Xu JJ; Tang R; Wang WJ; Liu P; Hu JL; Luo L; Jiang R; Zhu FC; Chen W
    Lancet Glob Health; 2017 Mar; 5(3):e324-e334. PubMed ID: 28017642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal delivery of plasmid encoding truncated nucleocapsid protein enhanced PRRSV-specific immune responses.
    Suradhat S; Wongyanin P; Sirisereewan C; Nedumpun T; Lumyai M; Triyarach S; Chaturavittawong D; Paphavasit T; Panyatong R; Thanawongnuwech R
    Vaccine; 2016 Jan; 34(5):609-615. PubMed ID: 26724543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
    Manjaly Thomas ZR; Satti I; Marshall JL; Harris SA; Lopez Ramon R; Hamidi A; Minhinnick A; Riste M; Stockdale L; Lawrie AM; Vermaak S; Wilkie M; Bettinson H; McShane H
    PLoS Med; 2019 Apr; 16(4):e1002790. PubMed ID: 31039172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.